Status: current, Defined. Date: 28-Feb 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 772721000036116 | Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 30 x 4 g sachets | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 792161000036118 | Keyomega (arachidonic acid and docosahexaenoic acid with carbohydrate containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid) powder for oral liquid, 30 x 4 g sachets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 30 x 4 g sachets | Is a | trade product pack | true | Inferred relationship | Some | ||
| Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 30 x 4 g sachets | Is a | arachidonic acid and docosahexaenoic acid with carbohydrate containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 30 x 4 g sachets | true | Inferred relationship | Some | ||
| Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 30 x 4 g sachets | has TPUU | Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 4 g sachet | true | Inferred relationship | Some | 1 | |
| Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 30 x 4 g sachets | has TP | Keyomega | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 30 x 4 g sachets | Is a | True | Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 30 x 4 g sachets | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR